ESC 365 - Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

ESC Premium Access

Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

Session: Heart failure with mid-range and preserved ejection fraction

Topic: Heart failure, other

Speaker: Professor G. Savarese (Stockholm, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)

64 presentations

13 followers

4 more presentations in this session

State of the Art: HFmrEF - The new middle child

Speaker: Professor R. De Boer (Rotterdam, NL)

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

Speaker: Doctor M. Gori (Bergamo, IT)

Should we abandon EF to stratify heart failure treatment?

Speaker: Professor S. Solomon (Boston, US)

Access the full session

Heart failure with mid-range and preserved ejection fraction

Speakers: Professor G. Savarese, Professor R. De Boer, Doctor A. Aimo, Doctor M. Gori, Professor S. Solomon

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources